Litalia MacFarlane says her experiences leading up to her MS diagnosis have convinced her that people mustn’t be shy about ...

Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

Therapeutic monoclonal antibodies (mAbs) are potent new tools for a molecular targeted approach to modify the course of multiple sclerosis (MS). Besides natalizumab, which was approved in 2006 ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

If you have multiple sclerosis, exposure to heat may cause symptoms like dizziness, sweating, and increased heart rate. To avoid these problems, read on for seven heat-beating tips. If you have ...

A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

Aug. 23, 2024 — A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

Generally, evidence notes that hypersexuality with multiple sclerosis (MS) is uncommon. A 2024 review investigating hypersexuality in neurological disorders wanted to include MS, but did not as ...

Demyelinating optic neuritis (DON) is a hallmark feature of multiple sclerosis (MS) and often occurrs as the heralding event of the disease. Optical coherence tomography has revolutionized the ...

Tolebrutinib delayed the onset of disability progression by 31% for patients with a type of the disease called non-relapsing ...